05.09.2024
Deepc has announced the completion of its series expansion round, raising an additional USD 13 million. This brings the total amount of funding to date to USD 30 million. The round was led by Sofinnova Partners and Bertelsmann Investments, with participation from new investors KHP Ventures and SwissHealth Ventures as well as existing investor Winning Mindset Ventures.
The additional funds will be used to accelerate deepc's growth and drive its international expansion. Particular priority will be given to expanding the company's presence in the USA, further expansion in the UK and a stronger presence in key European markets.
Deepc develops and distributes the leading AI operating system deepcOS®, which is used by renowned institutions such as the Solothurner Kantonsspital in Switzerland, the Vivantes Clinic Group and the LMU Klinikum in Germany, the CHU Brugmann in Belgium and the National Health Service (NHS) in England.
Dr. Franz Pfister, CEO and co-founder of deepc, commented: "We are convinced that the potential of AI in healthcare can only be fully realized if we bridge the gap between cutting-edge AI technology and clinical practice. Our platform enables organizations to integrate the best AI technologies quickly and at scale, leading to faster and more accurate diagnoses and ultimately improving patient care."
Simon Turner, Partner at Sofinnova Partners, added: "Investing in AI highlights the importance of technology driving adoption in healthcare. deepc has the potential to revolutionize AI adoption in healthcare and we are confident that the support from our new investors will further accelerate the company's growth."
Founded in 2019, deepc aims to ensure accurate and safe diagnoses for all patients and provides an integration solution for radiology AI providers, enabling seamless adoption of clinical AI technologies. Deepc has been a partner of the Health Innovation Network since 2022.
